We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.49B
AUM Growth
+$321M
Cap. Flow
+$178M
Cap. Flow %
11.93%
Top 10 Hldgs %
29.54%
Holding
140
New
9
Increased
64
Reduced
27
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 24.59%
2 Industrials 15.08%
3 Healthcare 14.66%
4 Materials 8.15%
5 Consumer Discretionary 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
26
Grand Canyon Education
LOPE
$3.93B
$28.7M 1.93%
658,615
+69,251
+12% +$3.04M
STMP
27
DELISTED
Stamps.com, Inc.
STMP
$27.8M 1.87%
661,210
+52,219
+9% +$2.34M
PRLB icon
28
Protolabs
PRLB
$2.11B
$27.7M 1.86%
389,792
-44,850
-10% -$3.48M
SPSC icon
29
SPS Commerce
SPSC
$2.67B
$27.1M 1.82%
830,950
+306,010
+58% +$10.4M
MDSO
30
DELISTED
Medidata Solutions, Inc.
MDSO
$27M 1.81%
445,927
+33,567
+8% +$1.86M
MCF
31
DELISTED
Contango Oil & Gas Co.
MCF
$26.6M 1.79%
563,896
+32,381
+6% +$1.42M
EGOV
32
DELISTED
NIC Inc
EGOV
$26.6M 1.79%
1,069,891
+139,150
+15% +$3.28M
VIVO
33
DELISTED
Meridian Bioscience Inc
VIVO
$26.3M 1.77%
991,512
+105,760
+12% +$2.6M
CRR
34
DELISTED
Carbo Ceramics Inc.
CRR
$26.1M 1.75%
223,601
+14,925
+7% +$1.7M
ROL icon
35
Rollins
ROL
$18.2B
$25.2M 1.7%
2,810,984
+188,258
+7% +$1.57M
HITT
36
DELISTED
HITTITE MICROWAVE CORP
HITT
$22.3M 1.5%
361,260
+27,065
+8% +$1.69M
MTDR icon
37
Matador Resources
MTDR
$6.06B
$20.3M 1.36%
1,089,034
+151,138
+16% +$2.97M
ACCL
38
DELISTED
Accelrys Inc
ACCL
$20.3M 1.36%
2,122,788
+166,138
+8% +$1.56M
MORN icon
39
Morningstar
MORN
$7.51B
$17.2M 1.15%
220,058
+11,155
+5% +$887K
NRC icon
40
NRC Health Common Stock
NRC
$434M
$16.9M 1.13%
897,191
-1,516
-0.2% -$26.6K
FDS icon
41
Factset
FDS
$9.76B
$15.8M 1.06%
145,162
+10,130
+8% +$1.12M
TECH icon
42
Bio-Techne
TECH
$11.2B
$15.5M 1.04%
655,352
+69,640
+12% +$1.51M
NVEC icon
43
NVE Corp
NVEC
$618M
$13.6M 0.91%
233,670
+55,663
+31% +$3.02M
AVAV icon
44
AeroVironment
AVAV
$8.55B
$12.3M 0.83%
422,960
+26,215
+7% +$705K
MLAB icon
45
Mesa Laboratories
MLAB
$566M
$11.7M 0.79%
148,856
+36,935
+33% +$2.69M
DORM icon
46
Dorman Products
DORM
$4.42B
$11.5M 0.77%
+204,857
New +$10.3M
MED icon
47
Medifast
MED
$145M
$9.49M 0.64%
363,170
+29,231
+9% +$749K
ACTG icon
48
Acacia Research
ACTG
$445M
$9.47M 0.64%
651,505
+46,237
+8% +$730K
NRCIB
49
DELISTED
National Research Corp Class B
NRCIB
$7.74M 0.52%
222,854
+51,157
+30% +$1.64M
EXA
50
DELISTED
EXA Corporation
EXA
$6.42M 0.43%
484,039
+163,215
+51% +$2.37M

Similar funds

Conestoga Capital Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Conestoga Capital Advisors held 140 positions worth $1.49B, up 28% from $1.17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors deployed $178M of net new capital in Q4 2013, opening 9 new positions and adding to 64 existing holdings. Its largest new stake was Dorman Products: 204,857 shares worth $11.5M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Protolabs, an estimated $3.48M trimmed.

  • Conestoga Capital Advisors's largest Q4 2013 buy was Dorman Products: 204,857 shares worth $11.5M.
  • Conestoga Capital Advisors added most to Fleetmatics Group PLC in Q4 2013, an estimated $12.8M increase.
  • Conestoga Capital Advisors's biggest Q4 2013 reduction was Protolabs, cutting an estimated $3.48M.
  • Conestoga Capital Advisors fully exited InnerWorkings, Inc. in Q4 2013, selling an estimated $9.94M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $1.49B portfolio in Q4 2013.
  • Conestoga Capital Advisors opened 9 new positions and closed 2 in Q4 2013.
  • Conestoga Capital Advisors's portfolio value rose 28% quarter-over-quarter to $1.49B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2013, filed 22 Jan 2014.